257 related articles for article (PubMed ID: 29739342)
21. Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis.
Rojas Sánchez P; Domínguez S; Jiménez De Ory S; Prieto L; Rojo P; Mellado P; Navarro M; Delgado R; Ramos JT; Holguín Á;
Pediatr Infect Dis J; 2018 Mar; 37(3):e48-e57. PubMed ID: 28991889
[TBL] [Abstract][Full Text] [Related]
22. Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.
Teto G; Tagny CT; Mbanya D; Fonsah JY; Fokam J; Nchindap E; Kenmogne L; Njamnshi AK; Kanmogne GD
Sci Rep; 2017 Oct; 7(1):14136. PubMed ID: 29074854
[TBL] [Abstract][Full Text] [Related]
23. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
[TBL] [Abstract][Full Text] [Related]
24. Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
Andrade SD; Sabidó M; Monteiro WM; Benzaken AS; Tanuri A
J Antimicrob Chemother; 2017 Jun; 72(6):1774-1783. PubMed ID: 28333295
[TBL] [Abstract][Full Text] [Related]
25. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
[TBL] [Abstract][Full Text] [Related]
26. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations.
de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE
J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783
[TBL] [Abstract][Full Text] [Related]
27. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.
Zhao B; Han X; Dai D; Liu J; Ding H; Xu J; Chu Z; Bice T; Diao Y; Shang H
AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1047-53. PubMed ID: 21417755
[TBL] [Abstract][Full Text] [Related]
28. Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand.
Sungkanuparph S; Sukasem C; Kiertiburanakul S; Pasomsub E; Chantratita W
J Int AIDS Soc; 2012 Mar; 15(1):12. PubMed ID: 22410286
[TBL] [Abstract][Full Text] [Related]
29. [Genotypic resistance mutations to antiretroviral drugs in newly confirmed human immunodeficiency virus infectors in Beijing].
Ye JR; Guo L; Lu HY; Xin RL; Zeng Y
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(21):1453-6. PubMed ID: 21914279
[TBL] [Abstract][Full Text] [Related]
30. Transmitted HIV-1 Drug Resistance in a Treatment-Naive Cohort of Recently Infected Individuals from Chennai, India.
Nesakumar M; Haribabu H; Cheedarla N; Karunaianantham R; Kailasam N; Sathyamurthi P; Selvachithiram M; Tripathy SP; Hanna LE
AIDS Res Hum Retroviruses; 2019 Aug; 35(8):775-779. PubMed ID: 31001987
[TBL] [Abstract][Full Text] [Related]
31. Diverse forms of HIV-1 among Burmese long-distance truck drivers imply their contribution to HIV-1 cross-border transmission.
Zhou YH; Liang YB; Pang W; Qin WH; Yao ZH; Chen X; Zhang C; Zheng YT
BMC Infect Dis; 2014 Aug; 14():463. PubMed ID: 25158600
[TBL] [Abstract][Full Text] [Related]
32. Drug resistance mutation profiles of the drug-naïve and first-line regimen-treated HIV-1-infected population of Suzhou, China.
Li T; Qian F; Yuan T; Xu W; Zhu L; Huang J; Wang H; Zhu Y; Wang Y; Li X; Gu S; Tan Z; Chen H; Luo X; Zhu W; Lu W; Xu P; Li M; Chen Y; Gao Y; Yang R; Zhu C; Sun B
Virol Sin; 2017 Aug; 32(4):271-279. PubMed ID: 28795354
[TBL] [Abstract][Full Text] [Related]
33. The characteristics of pretreatment HIV-1 drug resistance in western Yunnan, China.
Chen M; Zhu Q; Xing H; Chen H; Jin X; Dong L; Dai J; Yang M; Yang C; Jia M; Ma Y
Epidemiol Infect; 2020 May; 148():e102. PubMed ID: 32381145
[TBL] [Abstract][Full Text] [Related]
34. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China.
Zou X; He J; Zheng J; Malmgren R; Li W; Wei X; Zhang G; Chen X
Virol J; 2020 Mar; 17(1):38. PubMed ID: 32183889
[TBL] [Abstract][Full Text] [Related]
36. [Study on the drug resistance situation among recently infected HIV-1 patients in Dehong].
Wang MJ; Duan S; Xiang LF; Yang YC; Tu YQ; Wang JB; Yao J; Qi J; Jiang Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):905-8. PubMed ID: 19173856
[TBL] [Abstract][Full Text] [Related]
37. Genetic Diversity and Drug Resistance Among Antiretroviral Treatment-Failed Individuals from 2010 to 2012 in Honghe, China.
Yang C; Yang S; Li J; Yang B; Liu J; Li H; Bian Z
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):822-9. PubMed ID: 25919896
[TBL] [Abstract][Full Text] [Related]
38. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
[TBL] [Abstract][Full Text] [Related]
39. Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China.
Liu L; Dong A; Liao L; Feng Y; Shao Y; Liang S; Ruan Y; Xing H
Curr HIV Res; 2019; 17(6):441-451. PubMed ID: 31778107
[TBL] [Abstract][Full Text] [Related]
40. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.
Aghokeng AF; Kouanfack C; Laurent C; Ebong E; Atem-Tambe A; Butel C; Montavon C; Mpoudi-Ngole E; Delaporte E; Peeters M
AIDS; 2011 Nov; 25(17):2183-8. PubMed ID: 21860346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
